Malin Löwenmark

GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy

Timsina, Jigyasha; Jiang, Chenyang; McCartney, Daniel L.; Tao, Feifei et al.

Part of Nature Communications, 2026

• DOI for GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy
• Download full text (pdf) of GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy

Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus

Hofling, Ulrika; Jakobsson, Jenny; Erngren, Ida; Ekman, Oskar et al.

Part of Fluids and Barriers of the CNS, 2026

• DOI for Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus
• Download full text (pdf) of Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus

Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations

Nicolas, Aude; Sherva, Richard; Grenier-Boley, Benjamin; Kim, Yoontae et al.

Part of Nature Genetics, 2025

• DOI for Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations
• Download full text (pdf) of Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations

Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus

Georgiopoulos, Charalampos; Papadimitriou, Stergios; Nyholm, Dag; Kilander, Lena et al.

Part of Journal of Neuroimaging, p. 612-618, 2024

• DOI for Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus
• Download full text (pdf) of Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus

Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men

Kallström, Angelica; Giedraitis, Vilmantas; Franzon, Kristin; Löwenmark, Malin et al.

Part of International Journal of Geriatric Psychiatry, 2024

• DOI for Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men
• Download full text (pdf) of Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men

GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy

Timsina, Jigyasha; Jiang, Chenyang; McCartney, Daniel L.; Tao, Feifei et al.

Part of Nature Communications, 2026

• DOI for GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy
• Download full text (pdf) of GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy

Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus

Hofling, Ulrika; Jakobsson, Jenny; Erngren, Ida; Ekman, Oskar et al.

Part of Fluids and Barriers of the CNS, 2026

• DOI for Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus
• Download full text (pdf) of Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus

Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations

Nicolas, Aude; Sherva, Richard; Grenier-Boley, Benjamin; Kim, Yoontae et al.

Part of Nature Genetics, 2025

• DOI for Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations
• Download full text (pdf) of Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations

Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus

Georgiopoulos, Charalampos; Papadimitriou, Stergios; Nyholm, Dag; Kilander, Lena et al.

Part of Journal of Neuroimaging, p. 612-618, 2024

• DOI for Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus
• Download full text (pdf) of Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus

Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men

Kallström, Angelica; Giedraitis, Vilmantas; Franzon, Kristin; Löwenmark, Malin et al.

Part of International Journal of Geriatric Psychiatry, 2024

• DOI for Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men
• Download full text (pdf) of Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

Braun, Madelen; Boström, Gustaf; Ingelsson, Martin; Kilander, Lena et al.

Part of Fluids and Barriers of the CNS, 2023

• DOI for Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
• Download full text (pdf) of Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

Feasibility of PURPOSE T in clinical practice and patient participation: a mixed-method study

Hultin, Lisa; Karlsson, Ann-Christin; Löwenmark, Malin; Coleman, Susanne et al.

Part of International Wound Journal, p. 633-647, 2023

• DOI for Feasibility of PURPOSE T in clinical practice and patient participation: a mixed-method study
• Download full text (pdf) of Feasibility of PURPOSE T in clinical practice and patient participation: a mixed-method study

Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia

Pagnon de la Vega, María; Näslund, Carl; Brundin, RoseMarie; Lannfelt, Lars et al.

Part of BMC Genomics, 2022

• DOI for Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
• Download full text (pdf) of Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia

The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid beta fibril formation

de la Vega, Maria Pagnon; Giedraitis, Vilmantas; Michno, Wojciech; Kilander, Lena et al.

Part of Science Translational Medicine, 2021

• DOI for The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid beta fibril formation

Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism

Fällmar, David; Andersson, Oliver; Kilander, Lena; Löwenmark, Malin et al.

Part of Fluids and Barriers of the CNS, 2021

• DOI for Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism
• Download full text (pdf) of Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism

Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid

Boström, Gustaf; Freyhult, Eva; Virhammar, Johan; Alcolea, Daniel et al.

Part of Journal of Alzheimer's Disease, p. 629-640, 2021

• DOI for Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid
• Download full text (pdf) of Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid

Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease

Bergström, Sofia; Remnestål, Julia; Yousef, Jamil; Olofsson, Jennie et al.

Part of Annals of Clinical and Translational Neurology, p. 1456-1470, 2021

• DOI for Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
• Download full text (pdf) of Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease

Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers

Emami Khoonsari, Payam; Shevchenko, Ganna; Herman, Stephanie; Remnestal, Julia et al.

Part of Journal of Alzheimer's Disease, p. 639-651, 2019

• DOI for Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
• Download full text (pdf) of Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers

High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease

Gunnarsson, Malin Degerman; Ingelsson, Martin; Blennow, Kaj; Basun, Hans et al.

Part of Alzheimer's Research & Therapy, 2016

• DOI for High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease
• Download full text (pdf) of High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease

High Tau Levels in Cerebrospinal Fluid Predict Rapid Decline and Increased Dementia Mortality in Alzheimer's Disease

Degerman Gunnarsson, Malin; Lannfelt, Lars; Ingelsson, Martin; Basun, Hans et al.

Part of Dementia and Geriatric Cognitive Disorders, p. 196-206, 2014

• DOI for High Tau Levels in Cerebrospinal Fluid Predict Rapid Decline and Increased Dementia Mortality in Alzheimer's Disease

Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography

Degerman Gunnarsson, Malin; Lindau, M; Santillo, A F; Wall, Anders et al.

Part of Dementia and Geriatric Cognitive Disorders Extra, p. 472-481, 2013

• DOI for Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography

CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid

Giedraitis, Vilmantas; Glaser, Anna; Sarajärvi, Timo; Brundin, RoseMarie et al.

Part of Neuroscience Letters, p. 265-267, 2010

• DOI for CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid

Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Degerman Gunnarsson, Malin; Lindau, Maria; Wall, Anders; Blennow, K et al.

Part of Dementia and Geriatric Cognitive Disorders, p. 204-212, 2010

• DOI for Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Oligomerization partially explains the lowering of Aβ42 in Alzheimer's disease cerebrospinal fluid

Englund, Hillevi; Degerman Gunnarsson, Malin; Brundin, RoseMarie; Hedlund, Marie et al.

Part of Neuro-degenerative diseases, p. 139-147, 2009

• DOI for Oligomerization partially explains the lowering of Aβ42 in Alzheimer's disease cerebrospinal fluid

Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men: A Prospective, Population-Based Cohort Study

Sundelöf, Johan; Giedraitis, Vilmantas; Irizarry, Michael C; Sundström, Johan et al.

Part of Archives of Neurology, p. 256-63, 2008

• DOI for Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men: A Prospective, Population-Based Cohort Study

Reduction of Phosphorylated Tau during Memantine Treatment of Alzheimer's Disease

Degerman Gunnarsson, Malin; Kilander, Lena; Basun, Hans; Lannfelt, Lars

Part of Dementia and Geriatric Cognitive Disorders, p. 247-252, 2007

• DOI for Reduction of Phosphorylated Tau during Memantine Treatment of Alzheimer's Disease

Biomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer’s Disease

Degerman Gunnarsson, Malin

2013

• Download full text (pdf) of Biomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer’s Disease